FDA Adverse Event Injury Summary report: N

AFX

MDR report key: 5225800 · Received November 16, 2015

Report

Report Number
2031527-2015-00448
Event Type
Injury
Date Received
November 16, 2015
Date of Event
October 19, 2015
Report Date
October 19, 2015
Manufacturer
ENDOLOGIX, INC.
Product Code
MIH
PMA / PMN Number
P040002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

BASED UPON THE CLINICAL ASSESSMENT, THE REPORTED ENDOLEAK COULD NOT BE CONFIRMED, AND THE OUTCOME WAS, THEREFORE, INCONCLUSIVE. A MANUFACTURING RECORD REVIEW WAS PERFORMED AND THE LOT MET ALL RELEASE CRITERIA WITH NO ISSUES OR DEVIATIONS THAT WOULD EXPLAIN THE REPORTED EVENT. BASED UPON THE INVESTIGATION, THE ROOT CAUSE IS INCONCLUSIVE. NO DESIGN OR MANUFACTURING ISSUE WAS IDENTIFIED. THE CLINICAL REVIEW IDENTIFIED THE FOLLOWING FACTOR THAT MAY HAVE CONTRIBUTED TO THE PATIENT OUTCOME: ONE OF THE CUFFS WAS THE SAME SIZE DIAMETER AS THE MAIN BODY. ADDITIONAL DEVICE: MODEL BIFURCATED BA25-100/I16-40 LOT: W11-3742-002 REL. DATE: 11/30/2011 EXP. DATE: 7/31/2012.

Additional Manufacturer Narrative · 1

THE DEVICE INVOLVED IN THE EVENT WILL NOT BE RETURNED FOR EVALUATION AS IT REMAINS IMPLANTED IN THE PATIENT. IF ADDITIONAL INFORMATION PERTINENT TO THE INCIDENT IS OBTAINED, A FOLLOW-UP REPORT WILL BE SUBMITTED. ADDITIONAL DEVICES: MODEL: A28-28/C95 V INFRARENAL AORTIC EXTENSION, LOT: 1164433-021, REL. DATE (B)(6) 2014, EXP. DATE: 4/21/2015. MODEL: I20-20/C55F-SA LIMB AORTIC EXTENSION, LOT: 1252560-021, REL. DATE: (B)(6) 2014. EXP. DATE: 06/25/2017.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT HAD A PROCEDURE ON (B)(6) 2011 WITH A BIFURCATED, A SUPRARENAL AORTIC EXTENSION, AND TWO LIMB EXTENSIONS. A SECONDARY WAS PERFORMED WHEN THE PHYSICIAN FOUND A TYPE 3A ENDOLEAK AND IMPLANTED TWO INFRARENALS AND A LIMB EXTENSION TO CORRECT. SUBSEQUENTLY, PATIENT NOW PRESENTED WITH AN UNKNOWN TYPE ENDOLEAK. PATIENT WILL BE BROUGHT IN FOR FURTHER EVALUATION AND POSSIBLE SECONDARY INTERVENTION. ADDITIONAL INFORMATION RECEIVED FROM THE REP 12/17/2015: EVEN THOUGH A TYPE 3B LEAK WAS NOT CONFIRMED OR DENIED, THE PHYSICIAN ELECTED TO RE-LINE THE PATIENT WITH A GORE DEVICE BACK IN MID (B)(6).

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT HAD A PROCEDURE ON (B)(6) 2011 WITH A BIFURCATED, A SUPRARENAL AORTIC EXTENSION, AND TWO LIMB EXTENSIONS. A SECONDARY WAS PERFORMED WHEN THE PHYSICIAN FOUND A TYPE 3A ENDOLEAK AND IMPLANTED TWO INFRARENALS AND A LIMB EXTENSION TO CORRECT. SUBSEQUENTLY, PATIENT NOW PRESENTED WITH AN UNKNOWN TYPE ENDOLEAK. PATIENT WILL BE BROUGHT IN FOR FURTHER EVALUATION AND POSSIBLE SECONDARY INTERVENTION. NO PATIENT INJURY WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
755510 AFX INFRARENAL AORTIC EXTENSION MIH ENDOLOGIX, INC. A28-28/C95 V 1164431-026

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention